Want to see VTGN full AI Analyst Report?
VistaGen Therapeutics (VTGN) Stock Forecast & Price Target
VTGN Analyst Ratings
VTGN Stock 12 Month Forecast
There are no analyst price targets in the last 3 months.
Detailed List of Analyst Forecasts
| Price Target | Follow | Article | ||||||
|---|---|---|---|---|---|---|---|---|
| Myles Minter | William Blair | ― | hold | ― | Reiterated | 09/23/26 | ||
| Paul Matteis | Stifel Nicolaus | $1 | hold | 494.88%Upside | Reiterated | 07/06/26 | ||
| Jason McCarthy | Maxim Group | ― | hold | ― | Downgraded | 12/17/25 | ||
| Elemer Piros | Lucid Capital | $19→$1 | hold | 494.88%Upside | Downgraded | 12/17/25 | ||
| Andrew Tsai | Jefferies | $15→$0.90 | hold | 435.40%Upside | Downgraded | 12/17/25 |
| Price Target | Follow | Article | ||||||
|---|---|---|---|---|---|---|---|---|
| Myles Minter | 09/23/26 | ― | hold | ― | Reiterated | William Blair | ||
| Paul Matteis | 07/06/26 | $1 | hold | 494.88%Upside | Reiterated | Stifel Nicolaus | ||
| Jason McCarthy | 12/17/25 | ― | hold | ― | Downgraded | Maxim Group | ||
| Elemer Piros | 12/17/25 | $19→$1 | hold | 494.88%Upside | Downgraded | Lucid Capital | ||
| Andrew Tsai | 12/17/25 | $15→$0.90 | hold | 435.40%Upside | Downgraded | Jefferies |
Best Analysts Covering VistaGen Therapeutics
Copying PerPlexity Biotechnology's trades and holding each position for 3 Months would result in 33.33% of your transactions generating a profit, with an average return of -7.23% per trade.
Copying PerPlexity Biotechnology's trades and holding each position for 1 Year would result in 33.33% of your transactions generating a profit, with an average return of -7.23% per trade.
Copying PerPlexity Biotechnology's trades and holding each position for 2 Years would result in 33.33% of your transactions generating a profit, with an average return of -7.23% per trade.
VTGN Analyst Recommendation Trends
| Rating | May 26 | Jun 26 | Jul 26 | Aug 26 | Sep 26 |
|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 |
| Buy | 0 | 0 | 0 | 0 | 0 |
| Hold | 3 | 4 | 5 | 4 | 3 |
| Sell | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 |
| total | 3 | 4 | 5 | 4 | 3 |
In the current month, VTGN has received 0 Buy Ratings, 3 Hold Ratings, and 0 Sell Ratings. VTGN average Analyst price target in the past 3 months is ―.
VTGN Financial Forecast
VTGN Earnings Forecast
Next quarter’s earnings estimate for VTGN is -$0.38 with a range of -$0.38 to -$0.37. The previous quarter’s EPS was -$0.30. Its overall industry beat the EPS estimate 57.80% of the time in the past 12 months.
VTGN Sales Forecast
Next quarter’s sales forecast for VTGN is $500.00K with a range of $500.00K to $500.00K. The previous quarter’s sales results were $1.48M. Its overall industry beat sales estimates 50.04% of the time in the past 12 months.
